Lisa Yerian, M.D.
| Appointed: |
2004 |
| Gender: |
Female |
| Languages: |
English |
Anatomic Pathology
Transplantation Center
Biographical Sketch
Lisa Yerian, MD, was born in Zanesville, Ohio. After training in Gastrointestinal and Liver Pathology at the University of Chicago, she joined the Department of Anatomic Pathology at Cleveland Clinic in 2004.
She is Director of Hepatobiliary Pathology, and shares a joint appointment in the Transplantation Center. Dr. Yerian interprets liver and pancreas biopsy and resection specimens. She is also a member of the Gastrointestinal Pathology service at Cleveland Clinic and is also Assistant Professor of Pathology at the Lerner College of Medicine at Case Western Reserve University.
Dr. Yerian is board-certified in anatomic pathology and has many clinical interests, including the histologic diagnosis of liver and gastrointestinal diseases. Her specific research interests include fatty liver disease and the development of cancer in chronic hepatitis. Dr. Yerian has a longstanding commitment to pathology education and directs national courses in Liver Pathology and Gastrointestinal Pathology. She also participates in national education committees.
Education & Fellowships
| Medical School: | University of Chicago Pritzker School of Medicine, Chicago, IL |
|
| Residency: | University of Chicago Hospitals, Anatomic / Clinical Pathology, Chicago, IL |
| Fellowship: | University of Chicago Hospitals, Gastrointestinal and Liver Pathology, Chicago, IL |
| Other Education: | (Undergraduate) University of Notre Dame, Notre Dame, IN |
Certifications
Specialty Interests
Liver and gastrointestinal pathology.
Professional Memberships
- United States and Canadian Academy of Pathology
- Rodger C. Haggitt Gastrointestinal Pathology Society
- Hans Popper Hepatopathology Society
- American Association for the Study of Liver Diseases
- American Gastroenterological Association
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 9/4/2008, Dr. Yerian has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
